Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination

Por um escritor misterioso
Last updated 22 dezembro 2024
Class switch toward noninflammatory, spike-specific IgG4 antibodies after  repeated SARS-CoV-2 mRNA vaccination
Class switch toward noninflammatory, spike-specific IgG4 antibodies after  repeated SARS-CoV-2 mRNA vaccination
Class switch towards spike protein-specific IgG4 antibodies after SARS-CoV-2 mRNA vaccination depends on prior infection history
Class switch toward noninflammatory, spike-specific IgG4 antibodies after  repeated SARS-CoV-2 mRNA vaccination
SARS-CoV-2 vaccination diversifies the CD4+ spike-reactive T cell repertoire in patients with prior SARS-CoV-2 infection - eBioMedicine
Class switch toward noninflammatory, spike-specific IgG4 antibodies after  repeated SARS-CoV-2 mRNA vaccination
Antibody Fc-binding profiles and ACE2 affinity to SARS-CoV-2 RBD variants
Class switch toward noninflammatory, spike-specific IgG4 antibodies after  repeated SARS-CoV-2 mRNA vaccination
Frontiers mRNA vaccines against SARS-CoV-2 induce comparably low long-term IgG Fc galactosylation and sialylation levels but increasing long-term IgG4 responses compared to an adenovirus-based vaccine
Class switch toward noninflammatory, spike-specific IgG4 antibodies after  repeated SARS-CoV-2 mRNA vaccination
The BNT162b2 mRNA SARS-CoV-2 vaccine induces transient afucosylated IgG1 in naive but not in antigen-experienced vaccinees - eBioMedicine
Class switch toward noninflammatory, spike-specific IgG4 antibodies after  repeated SARS-CoV-2 mRNA vaccination
Class switch towards spike protein-specific IgG4 antibodies after SARS-CoV-2 mRNA vaccination depends on prior infection history
Class switch toward noninflammatory, spike-specific IgG4 antibodies after  repeated SARS-CoV-2 mRNA vaccination
Non-neutralizing functions in anti-SARS-CoV-2 IgG antibodies - ScienceDirect
Class switch toward noninflammatory, spike-specific IgG4 antibodies after  repeated SARS-CoV-2 mRNA vaccination
Class switch towards non-inflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination – ScienceOpen
Class switch toward noninflammatory, spike-specific IgG4 antibodies after  repeated SARS-CoV-2 mRNA vaccination
Repeat SARS-CoV-2 mRNA Vaccination Tied to Rise in Unexpected Antibody Subset
Class switch toward noninflammatory, spike-specific IgG4 antibodies after  repeated SARS-CoV-2 mRNA vaccination
Class switch towards non-inflammatory IgG isotypes after repeated SARS-CoV-2 mRNA vaccination
Class switch toward noninflammatory, spike-specific IgG4 antibodies after  repeated SARS-CoV-2 mRNA vaccination
Efficacy of mRNA-1273 and Novavax ancestral or BA.1 spike booster vaccines against SARS-CoV-2 BA.5 infection in nonhuman primates
Class switch toward noninflammatory, spike-specific IgG4 antibodies after  repeated SARS-CoV-2 mRNA vaccination
Both COVID-19 infection and vaccination induce high-affinity cross-clade responses to SARS-CoV-2 variants - ScienceDirect

© 2014-2024 immanuelipc.com. All rights reserved.